Immunocore Ownership | Who Owns Immunocore?
Immunocore Ownership Summary
Immunocore is owned by 96.14% institutional investors, 5.08% insiders. T. rowe price investment management is the largest institutional shareholder, holding 14.05% of IMCR shares. Vanguard Health Care Inv is the top mutual fund, with 6.26% of its assets in Immunocore shares.
IMCR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunocore | 96.14% | 5.08% | -1.22% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| T. rowe price investment management | 7.07M | 14.05% | $221.78M |
| Wellington management group llp | 6.62M | 13.23% | $195.20M |
| Rtw investments, lp | 4.87M | 9.68% | $152.81M |
| Fmr | 4.82M | 9.63% | $142.12M |
| Primecap management co/ca/ | 3.77M | 7.50% | $118.35M |
| Bellevue group | 2.44M | 4.86% | $76.62M |
| Baker bros. advisors lp | 2.32M | 4.62% | $72.88M |
| Price t rowe associates inc /md/ | 2.19M | 4.37% | $64.53M |
| Tang capital management | 2.11M | 4.19% | $66.07M |
| Deep track capital, lp | 1.80M | 3.58% | $56.48M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 2.11M | 3.34% | $66.07M |
| Kynam capital management, lp | 976.27K | 3.30% | $30.64M |
| Rtw investments, lp | 4.87M | 2.18% | $152.81M |
| Logos global management lp | 575.00K | 2.00% | $18.04M |
| Deep track capital, lp | 1.80M | 1.81% | $56.48M |
| Bellevue group | 2.44M | 1.69% | $76.62M |
| Bvf inc/il | 1.02M | 1.15% | $32.14M |
| Eschler asset management llp | 40.00K | 0.95% | $1.26M |
| Baker bros. advisors lp | 2.32M | 0.71% | $72.88M |
| Frazier life sciences management | 384.78K | 0.48% | $12.07M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bellevue group | 2.44M | 1.69% | 1.22M |
| Primecap management co/ca/ | 3.77M | 0.09% | 1.09M |
| Bvf inc/il | 1.02M | 1.15% | 1.02M |
| Citigroup | 632.94K | 0.01% | 616.91K |
| Logos global management lp | 575.00K | 2.00% | 575.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -1.79M |
| General atlantic | - | - | -1.26M |
| Braidwell lp | - | - | -797.27K |
| Kynam capital management, lp | 976.27K | 3.30% | -719.31K |
| Pictet asset management sa | - | - | -706.61K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bvf inc/il | 1.02M | 1.15% | 1.02M | $32.14M |
| Logos global management lp | 575.00K | 2.00% | 575.00K | $18.04M |
| Bnp paribas arbitrage, snc | 193.12K | 0.00% | 193.12K | $5.70M |
| Lazard asset management | 88.89K | 0.00% | 88.89K | $2.79M |
| Y-intercept (hong kong) | 51.66K | 0.04% | 51.66K | $1.62M |
Sold Out
| Holder | Change |
|---|---|
| J.safra asset management | -5.00 |
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Ronald blue trust | -6.00 |
| Northwestern mutual wealth management | -7.00 |
| Geneos wealth management | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 141 | 11.90% | 48,351,355 | 0.95% | 96 | 1.05% | 74 | 23.33% | 40 | 25.00% |
| Mar 31, 2025 | 125 | 2.46% | 47,879,396 | 4.09% | 95 | 1.13% | 61 | 24.49% | 31 | -31.11% |
| Dec 31, 2024 | 76 | -45.71% | 20,547,400 | -54.62% | 41 | 0.50% | 28 | -57.58% | 28 | -26.32% |
| Sep 30, 2024 | 138 | -6.76% | 45,248,455 | 3.71% | 90 | 1.18% | 64 | -23.81% | 37 | 15.63% |
| Jun 30, 2024 | 145 | -9.94% | 43,628,132 | 5.90% | 87 | 1231365.60% | 82 | -9.89% | 31 | -27.91% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 3.15M | 6.26% | -1.44M |
| Vanguard Capital Opportunity Inv | 2.44M | 4.86% | 682.68K |
| T. Rowe Price US Small-Cap Core Equity | 2.06M | 4.10% | 195.97K |
| T. Rowe Price Small-Cap Stock | 2.06M | 4.10% | 44.92K |
| Fidelity Growth Compy Commingled Pl S | 1.44M | 2.87% | 8.44K |
| BB Biotech AG Ord | 1.21M | 2.41% | - |
| Fidelity Growth Compy Commingled Pl O | 1.15M | 2.30% | 101.00 |
| PRIMECAP Odyssey Aggressive Growth | 1.11M | 2.22% | 365.18K |
| T. Rowe Price Instl Small-Cap Stock | 1.08M | 2.15% | 1.80K |
| T. Rowe Price Small-Cap Value | 1.07M | 2.14% | -1.26K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 17, 2025 | BAKER BROS. ADVISORS LP | - | Buy | $1.79M |
| Mar 17, 2025 | BAKER BROS. ADVISORS LP | - | Buy | $253.89K |
| Mar 17, 2025 | BAKER BROS. ADVISORS LP | - | Buy | $19.22M |
| Mar 17, 2025 | BAKER BROS. ADVISORS LP | - | Buy | $2.73M |
| Mar 17, 2025 | BAKER BROS. ADVISORS LP | - | Sell | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 4 | 1 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 12 |
IMCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools